Deeks SG - Search Results

1

Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons.

Choi AI, Vittinghoff E, Deeks SG, Weekley CC, Li Y, Shlipak MG. Choi AI, et al. Among authors: deeks sg. AIDS. 2011 Jun 19;25(10):1289-98. doi: 10.1097/QAD.0b013e328347fa16. AIDS. 2011. PMID: 21516027 Free PMC article.

2

Activity of a ritonavir plus saquinavir-containing regimen in patients with virologic evidence of indinavir or ritonavir failure.

Deeks SG, Grant RM, Beatty GW, Horton C, Detmer J, Eastman S. Deeks SG, et al. AIDS. 1998 Jul 9;12(10):F97-102. doi: 10.1097/00002030-199810000-00002. AIDS. 1998. PMID: 9677159

3

Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans.

Hellerstein M, Hanley MB, Cesar D, Siler S, Papageorgopoulos C, Wieder E, Schmidt D, Hoh R, Neese R, Macallan D, Deeks S, McCune JM. Hellerstein M, et al. Nat Med. 1999 Jan;5(1):83-9. doi: 10.1038/4772. Nat Med. 1999. PMID: 9883844

4

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy.

Deeks SG, Hecht FM, Swanson M, Elbeik T, Loftus R, Cohen PT, Grant RM. Deeks SG, et al. AIDS. 1999 Apr 16;13(6):F35-43. doi: 10.1097/00002030-199904160-00001. AIDS. 1999. PMID: 10397555

5

Loss of antiretroviral drug susceptibility at low viral load during early virological failure in treatment-experienced patients.

Parkin NT, Deeks SG, Wrin MT, Yap J, Grant RM, Lee KH, Heeren D, Hellmanna NS, Petropoulos CJ. Parkin NT, et al. Among authors: deeks sg. AIDS. 2000 Dec 22;14(18):2877-87. doi: 10.1097/00002030-200012220-00009. AIDS. 2000. PMID: 11153669 Clinical Trial.

6

Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.

Deeks SG, Wrin T, Liegler T, Hoh R, Hayden M, Barbour JD, Hellmann NS, Petropoulos CJ, McCune JM, Hellerstein MK, Grant RM. Deeks SG, et al. N Engl J Med. 2001 Feb 15;344(7):472-80. doi: 10.1056/NEJM200102153440702. N Engl J Med. 2001. PMID: 11172188 Free article. Clinical Trial.

7

Protease inhibitor-resistant HIV-1 from patients with preserved CD4 cell counts is cytopathic in activated CD4 T lymphocytes.

Liegler TJ, Hayden MS, Lee KH, Hoh R, Deeks SG, Granta RM. Liegler TJ, et al. Among authors: deeks sg. AIDS. 2001 Jan 26;15(2):179-84. doi: 10.1097/00002030-200101260-00006. AIDS. 2001. PMID: 11216925

8

Antiretroviral agents: the next generation.

Deeks SG. Deeks SG. AIDS Clin Care. 1998 May;10(5):33-6, 39-40. AIDS Clin Care. 1998. PMID: 11365427

9

Cerebrospinal fluid response to structured treatment interruption after virological failure.

Price RW, Paxinos EE, Grant RM, Drews B, Nilsson A, Hoh R, Hellmann NS, Petropoulos CJ, Deeks SG. Price RW, et al. Among authors: deeks sg. AIDS. 2001 Jul 6;15(10):1251-9. doi: 10.1097/00002030-200107060-00006. AIDS. 2001. PMID: 11426069

10

Hydroxyurea does not enhance the anti-HIV activity of low-dose tenofovir disoproxil fumarate.

Deeks SG, Barditch-Crovo P, Collier A, Smith A, Miller M, McGowan I, Coakley DF. Deeks SG, et al. J Acquir Immune Defic Syndr. 2001 Dec 1;28(4):336-9. doi: 10.1097/00126334-200112010-00005. J Acquir Immune Defic Syndr. 2001. PMID: 11707669 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

694 results

Search Page

Filters